These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Formulation and characterization of catechin-loaded proniosomes for food fortification. Shruthi PA; Pushpadass HA; Magdaline Eljeeva Emerald F; Surendra Nath B; Laxmana Naik N J Sci Food Agric; 2021 Apr; 101(6):2439-2448. PubMed ID: 33027542 [TBL] [Abstract][Full Text] [Related]
5. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations. Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402 [TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414 [TBL] [Abstract][Full Text] [Related]
7. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. Aboelwafa AA; El-Setouhy DA; Elmeshad AN AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration. Nasr M AAPS PharmSciTech; 2010 Mar; 11(1):85-9. PubMed ID: 20058106 [TBL] [Abstract][Full Text] [Related]
9. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs. Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828 [TBL] [Abstract][Full Text] [Related]
10. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. El-Laithy HM; Shoukry O; Mahran LG Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658 [TBL] [Abstract][Full Text] [Related]
11. α-Tocopherol-loaded niosome prepared by heating method and its release behavior. Basiri L; Rajabzadeh G; Bostan A Food Chem; 2017 Apr; 221():620-628. PubMed ID: 27979250 [TBL] [Abstract][Full Text] [Related]
12. Effect of Different Carriers on In Vitro and In Vivo Drug Release Behavior of Aceclofenac Proniosomes. Sammour RMF; Chatterjee B; Taher M; Saleh MSM; Shahiwala A Curr Drug Deliv; 2021; 18(9):1272-1279. PubMed ID: 33605859 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. Ruckmani K; Sankar V; Sivakumar M J Biomed Nanotechnol; 2010 Feb; 6(1):43-51. PubMed ID: 20499831 [TBL] [Abstract][Full Text] [Related]
14. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Khan MI; Madni A; Peltonen L Eur J Pharm Sci; 2016 Dec; 95():88-95. PubMed ID: 27600819 [TBL] [Abstract][Full Text] [Related]
15. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability. Zidan AS; Mokhtar Ibrahim M; Megrab NAE Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol entrapped niosomes as yoghurt additive. Pando D; Beltrán M; Gerone I; Matos M; Pazos C Food Chem; 2015 Mar; 170():281-7. PubMed ID: 25306346 [TBL] [Abstract][Full Text] [Related]
17. Stability of resveratrol esters with caprylic acid during simulated in vitro gastrointestinal digestion. Hu XP; Yin FW; Zhou DY; Xie HK; Zhu BW; Ma XC; Tian XG; Wang C; Shahidi F Food Chem; 2019 Mar; 276():675-679. PubMed ID: 30409647 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers for the topical delivery of tretinoin. Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827 [TBL] [Abstract][Full Text] [Related]
19. Optimization of transdermal atorvastatin calcium - Loaded proniosomes: Restoring lipid profile and alleviating hepatotoxicity in poloxamer 407-induced hyperlipidemia. Eltellawy YA; El-Kayal M; Abdel-Rahman RF; Salah S; Shaker DS Int J Pharm; 2021 Jan; 593():120163. PubMed ID: 33309831 [TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of proniosomes containing lornoxicam. Madan JR; Ghuge NP; Dua K Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]